An individual’s ancestral background, determined by where generations of their ancestors came from, shapes their genetic composition. How an individual identifies their race, ethnicity and ancestry (REA) helps to understand their genetic composition and is used in transplant clinical research and operations. Collecting more detailed race, ethnicity, and ancestry data provides better access to transplants and cellular therapies, helps to identify the need for more refined patient populations and supports future research.
With the October 2025 Quarterly Release, CIBMTR approved an expanded race, ethnicity, and ancestry list to meet the US Office of Management and Business (OMB) Statistical Policy Directive No.15: Standard of Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity requirements, harmonize with NMDP donor race, ethnicity and ancestry data and better align with clinical and operational needs of the transplant cellular therapy community. The OMB is taking this action to meet its responsibilities to update standards that enhance the ability to compare data across federal agencies and to understand how well federal programs serve a diverse America.
Form 2807 captures this data by collecting information on geographic ancestry and applicable details.
Additional information on Form 2807: